ISABEL BETANCOURT: Open Payments
NPI 1447707880 · ORLAND PARK, IL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,959 in 72 payments from 21 companies in 2025. Trend: 2023 $3,202 · 2024 $5,202 · 2025 $2,959
Food & beverage: $2,859Education: $100
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 13 | $1,095 |
| Astellas Pharma US Inc | 5 | $299 |
| Sumitomo Pharma America, Inc. | 11 | $239 |
| PFIZER INC. | 8 | $150 |
| Bayer Healthcare Pharmaceuticals Inc. | 6 | $141 |
| Novartis Pharmaceuticals Corporation | 6 | $132 |
| Janssen Pharmaceuticals, Inc | 1 | $125 |
| ABBVIE INC. | 1 | $125 |
| TOLMAR, INC. | 2 | $124 |
| PROGENICS PHARMACEUTICALS, INC. | 5 | $112 |
Products named: RYBREVANT, ERLEADA, XTANDI, ORGOVYX, Nubeqa, PLUVICTO, SPRAVATO, LINZESS.
Industry payments across IL — which companies pay providers there.
